IN 1 HOUR: Guggenheim Grand Rounds: Discussing Freenome SimpleScreen V2 Prospective Data Readout & Implications for the CRC Screening Space

Research evidence excerpt

IN 1 HOUR: Guggenheim Grand Rounds: Discussing Freenome SimpleScreen V2 Prospective Data Readout & Implications for the CRC Screening Space

DIAGNOSTICS & LIFE SCIENCES TOOLS

July 14, 2026

DISCLAIMER

Please forward the language below to your Compliance team: Guggenheim Securities, LLC

is providing notice to you and your firm’s Compliance department that we have invited

personnel from your firm to attend the above-referenced event. Attendees are advised that

any information or materials discussed at the event or provided in connection therewith

(the “materials”) are provided for informational and educational purposes only and should

not be considered a recommendation of any particular security, strategy or investment

product, as investing advice of any kind, or as offering or providing any investment product

or service, or as an offer or solicitation with respect to the purchase or sale of any

investment by Guggenheim Securities, LLC or any of its affiliates (“Guggenheim”). The

materials are not provided in an advisory or fiduciary capacity and may not be relied

upon for or in connection with the making of investment decisions. The views expressed

during the event and/or in the materials are solely those of the authors, participants,

investment bankers and other presenters (collectively, the “Presenters”) and may differ from

the views of other officers, directors, employees or other representatives (as to any person

or entity, its “Representatives”) of Guggenheim or any other Presenter. The Presenters’

opinions are subject to change without notice. Neither Guggenheim nor any other Presenter

undertakes any obligation to provide additional information or any update to or correction

of the information discussed or provided at the event or otherwise in connection therewith.